Navigation Links
Genomma Lab, New Participant in Market-Maker Program
Date:1/12/2009

MEXICO CITY, Jan. 12 /PRNewswire-FirstCall/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or "the Company") announced that on January 9, 2009, the Company signed an agreement with IXE Casa de Bolsa, S.A. de C.V. to act as the market maker for the Company's outstanding shares, thus becoming another company to participate in the market maker program. The contract will become valid upon approval of the Mexican Stock Exchange (Bolsa Mexicana de Valores) and will be in effect for a minimum period of 12 months from the date of the agreement.

Less than 6 months since becoming a public company, Genomma Lab seeks to leverage the benefits of the modernizing Mexican markets via the market-maker program. The Company expects that its incorporation into this program will allow for increased share liquidity.

With its incorporation into the market-maker program and together with the Share Repurchase program approved by the Board of Directors, Genomma Lab reaffirms its commitment to provide higher liquidity for its shares.

Company Description

Genomma Lab Internacional, S.A.B. de C.V. is a leading over-the-counter pharmaceuticals and personal care products company in Mexico with international presence. Genomma develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share.

Genomma Lab performed its Initial Public Offering in June 2008, through a combined offering (mainly primary) and is listed on the Mexican Stock Exchange under the ticker symbol "LAB.B" (Bloomberg: labb.mx).

    Web Site: www.genommalab.com

    Investor Relations Contact:
    Tel: +52 (55) 5081 0000 Ext. 4250
    E-mail: inversion@genommalab.com

    In New York: i-advize Corporate Communications, Inc.
    Tel: (212) 406-3691/95
    E-mail: genomma@i-advize.com

'/>"/>
SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Genomma Lab Announces Initiation of Stock Repurchase Fund
2. Genomma Lab Announces the Successful Launch of the Ma Evans Brand
3. Genomma Lab Announces 2009 Earnings Guidance
4. Genomma Lab Internacional Acquires UNIGASTROZOL
5. Webcast Alert: Genomma Lab Internacional, S.A.B. de C.V. announces Second Quarter 2008 Results Conference Call
6. Genomma Lab Prices Initial Public Offering and Begins Trading on Mexican Stock Exchange
7. Exercising Power to Lead Healthier Lives - 740,000 Participants Cast Votes for Challenger of Year
8. Newport Introduces More Resources for Spanish Speaking Plan Participants
9. Retired Heart Surgeon Dr. Dwight Lundell Celebrates 65th Birthday as an Ironman Participant
10. 25,000 AIDS Walk San Francisco Participants; 25,000 Reasons Why
11. Fight Against Breast Cancer Receives Big Boost During Susan G. Komen Detroit Race for the Cure(R) With 344 Participants From Binsons, Northwood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 08, 2016 , ... Stephanie Hebert Insurance Agency, serving families ... new charity campaign. As part of their ongoing community involvement program, funds are ... that children deserve a voice, and in the spirit of neighbors helping neighbors ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... expansion into Canada to provide its range of unique and advantaged protective ... Quebec City that will provide bilingual customer service and marketing support. A new ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... announced today that nominations will be accepted February 8, 2016 through May ... , Awards include the Information Security Executive® of the Year, which recognizes ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort with substantially ... to make a change in public health,” states Carole Baggerly, Director of GrassrootsHealth, ...
(Date:2/8/2016)... , ... February 08, 2016 , ... The schedule ... in this country. The AutismOne 2016 Conference, which is being held May 25-29 at ... won’t hear elsewhere about helpful interventions and causes of chronic illness in children. , ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... DIEGO , Feb. 8, 2016  Neurocrine Biosciences, ... Company will report its fourth quarter and year-end 2015 ... 11, 2016.  Neurocrine will then host a live conference ... provide a Company update Thursday afternoon, February 11, 2016 ... http://www.neurocrine.com . --> http://www.neurocrine.com . ...
(Date:2/8/2016)... --> --> ... Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, ... Ophthalmology, Gynecology) - Global Forecasts to 2020", published by ... forecast period of 2015 to 2020. The market is ... of 10.5% from 2015 to 2020. Browse ...
(Date:2/8/2016)... Feb. 8, 2016 Nueterra, the ... specialized in the development of equity partnerships ... it has divided its interests between two ... Capital will continue the founding company,s private ... operate a national system of integrated provider ...
Breaking Medicine Technology: